The largest number of changes in gene expression (n = 8) between tumour and non-malignant groups were identified in metabolic genes (PFKL, ATP5A1, UQCRFS1, CPT2, COX5A, ACLY, GPD2, and G6PD). This evidence concerns the gene CPT2 and neoplasm.